Friday, July 17, 2026

Clinical Tools · Trial Operations · ICH E9

Clinical Trial Randomization Generator

Generate an educational subject-level allocation sequence for simple randomization or permuted block randomization. Supports 2–4 treatment arms, custom allocation weights, optional block sizes, and deterministic seeded CSV export for protocol drafts and biostatistics review.

Quick Answer

Clinical trial randomization assigns subjects to treatment arms by chance per ICH E9, reducing selection bias and supporting valid treatment comparisons. Permuted block randomization balances arms within each block; simple randomization assigns each subject independently by allocation weights. Document the method, allocation ratio, block sizes (if used), and seed in the protocol and statistical analysis plan (SAP) — production schedules require validated RTSM or IRT systems with allocation concealment, not browser-generated lists.

ICH E9 context

Randomization protects trial comparisons by reducing selection bias and supporting comparability of treatment groups.

The randomization process should be prospectively specified, reproducible, concealed from those enrolling subjects, and appropriate for the trial design.

Generate Randomization Schedule

Use this educational generator for planning examples, protocol drafts, and biostatistics discussions. Do not use browser-generated schedules as final production randomization lists.

Methods Simple weighted Permuted block
Method & enrollment

Maximum 10,000 rows in the browser.

Allocation & study arms

Examples: 1:1, 2:1, 2:1:1, or 1,1,1,1.

Comma-separated sizes. Each must be a multiple of the ratio total.

Enter 2-4 arms, one per line or comma-separated.

Reproducibility

Same inputs and seed produce the same output.

Generated schedule

-

Enter parameters and generate to view the allocation summary.

Production warning: Final randomization schedules require validated generation, independent quality control, allocation concealment, controlled access, audit trails, and study-specific approval before use.
First generated assignments
Subject Assignment

How Randomization Supports ICH E9 Principles

ICH E9 describes randomization as a central design feature for avoiding selection bias and supporting valid treatment comparisons. A random element in treatment assignment helps make groups comparable at baseline, while the protocol and statistical analysis plan should define the method clearly enough for reproducibility.

Randomization is not just a number generator. It sits inside a broader quality system that includes allocation concealment, eligibility checks before assignment, documentation of who can access the schedule, and controls that prevent treatment prediction during enrollment.

Allocation Concealment and Operational Controls

Concealment

Investigators and site staff should not be able to know or predict the next assignment before a subject is irreversibly randomized.

Block confidentiality

Fixed block sizes can become predictable, especially in open-label studies. Randomly varying block sizes are often used, but the set of possible sizes should remain confidential.

Access control

Production schedules should be generated, stored, and released through validated systems with role-based access, audit trails, and documented quality checks.

Unblinding

Emergency unblinding and blinded supply workflows need study-specific controls. A CSV list is not a substitute for an RTSM or IRT process.

Stratification Caveat

Stratified randomization creates separate randomization schedules within defined strata such as region, disease stage, biomarker status, or prior therapy. This page generates one unstratified sequence only. If your design requires stratification, the block logic should be applied separately within each stratum and integrated into a controlled randomization workflow.

RTSM and IRT Workflow Caveats

  • RTSM or IRT systems typically randomize only after eligibility is confirmed and enrollment data pass edit checks.
  • Drug supply, kit assignment, replacement subjects, country release, cohort rules, and dose-level escalation can all affect assignment workflows.
  • Blinded and open-label trials have different concealment risks, especially when allocation ratios are unequal or block sizes are small.
  • Adaptive, response-adaptive, minimization, cluster, crossover, and platform trials may require methods beyond simple or permuted block randomization.

Worked Example

Two-arm 1:1 permuted block schedule

Inputs: arms are Control and Investigational drug; ratio is 1:1; total subjects is 24; block sizes are 4 and 6; seed is NPN-ICH-E9-001.

Interpretation: each complete block contains equal numbers of Control and Investigational drug assignments, shuffled within the block using the seed. If the requested total stops part-way through a block, the final partial block may not be perfectly balanced.

Operational note: the generated CSV is suitable for educational review, not for direct release to sites or study teams.

Pharma & Clinical Trial Context

Randomization specifications belong in the protocol synopsis and statistical analysis plan (SAP) before first patient in. Sponsors document the method (simple vs permuted block), allocation ratio, stratification factors (if any), block size rules, and reproducibility approach so biostatistics, data management, and clinical operations can align on allocation concealment and RTSM or IRT configuration.

Use this generator during protocol drafting to illustrate expected balance patterns and seed reproducibility — then size the trial with the Sample Size Calculator, map visit windows with the Visit Schedule Generator, and draft protocol sections via the Protocol Synopsis tool. For treatment-effect framing after sizing, use the Confidence Interval Calculator and NNT Calculator.

Production enrollment runs through validated RTSM or IRT platforms with role-based access, audit trails, emergency unblinding, and drug-supply integration. Final randomization lists require independent QC and version control under sponsor SOPs — not browser CSV export.

Evidence & Sources

Frequently Asked Questions

Related Clinical Tools